ADAR1 Capital Management, LLC

Holdings History for Corvus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (CRVS)

Symbol: CRVS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0.27%	+0.27%	$3,587,238	465,875	+465,875	NEW	$7.70	Q4 2025
31 Mar 2025	call		-0.35%	$0	0	-10,000	-100%	$19.74	Q1 2025
31 Mar 2025	put		-0.53%	$0	0	-15,000	-100%	$19.74	Q1 2025
31 Dec 2024	call	0.35%	+0.35%	$53,500	10,000	+10,000	NEW	$5.35	Q4 2024
31 Dec 2024	put	0.53%	+0.53%	$80,250	15,000	+15,000	NEW	$5.35	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.